Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,924,820
-
Share change
-
+122,423
-
Total reported value
-
$42,872,000
-
Price per share
-
$5.41
-
Number of holders
-
31
-
Value change
-
+$824,141
-
Number of buys
-
15
-
Number of sells
-
8
Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) as of Q4 2017
As of 31 Dec 2017,
AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,924,820 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, ORBIMED ADVISORS LLC, JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO, Rock Springs Capital Management LP, DAFNA Capital Management LLC, Vanguard Group Inc, BRIDGEWAY CAPITAL MANAGEMENT INC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.